352 related articles for article (PubMed ID: 36902074)
1. The Effects of
Richter E; Geetha T; Burnett D; Broderick TL; Babu JR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902074
[TBL] [Abstract][Full Text] [Related]
2. Effects of dietary wild bitter melon (Momordica charantia var. abbreviate Ser.) extract on glucose and lipid metabolism in HFD/STZ-induced type 2 diabetic rats.
Sun K; Ding M; Fu C; Li P; Li T; Fang L; Xu J; Zhao Y
J Ethnopharmacol; 2023 Apr; 306():116154. PubMed ID: 36634725
[TBL] [Abstract][Full Text] [Related]
3. Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.
Leung L; Birtwhistle R; Kotecha J; Hannah S; Cuthbertson S
Br J Nutr; 2009 Dec; 102(12):1703-8. PubMed ID: 19825210
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
[TBL] [Abstract][Full Text] [Related]
5. Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer's Disease.
Li R; Zhang Y; Rasool S; Geetha T; Babu JR
Oxid Med Cell Longev; 2019; 2019():8165707. PubMed ID: 30800211
[TBL] [Abstract][Full Text] [Related]
6. The Role of
Fan M; Kim EK; Choi YJ; Tang Y; Moon SH
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31487939
[No Abstract] [Full Text] [Related]
7. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.
Peter EL; Kasali FM; Deyno S; Mtewa A; Nagendrappa PB; Tolo CU; Ogwang PE; Sesaazi D
J Ethnopharmacol; 2019 Mar; 231():311-324. PubMed ID: 30385422
[TBL] [Abstract][Full Text] [Related]
8. Bioactives of
Xu B; Li Z; Zeng T; Zhan J; Wang S; Ho CT; Li S
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408574
[No Abstract] [Full Text] [Related]
9. Momordica charantia and type 2 diabetes: from in vitro to human studies.
Habicht SD; Ludwig C; Yang RY; Krawinkel MB
Curr Diabetes Rev; 2014 Jan; 10(1):48-60. PubMed ID: 24295371
[TBL] [Abstract][Full Text] [Related]
10. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
Raina K; Kumar D; Agarwal R
Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
[TBL] [Abstract][Full Text] [Related]
11. Bitter gourd (Momordica Charantia): A dietary approach to hyperglycemia.
Krawinkel MB; Keding GB
Nutr Rev; 2006 Jul; 64(7 Pt 1):331-7. PubMed ID: 16910221
[TBL] [Abstract][Full Text] [Related]
12. Bitter melon (Momordica charantia): a review of efficacy and safety.
Basch E; Gabardi S; Ulbricht C
Am J Health Syst Pharm; 2003 Feb; 60(4):356-9. PubMed ID: 12625217
[TBL] [Abstract][Full Text] [Related]
13. Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11β-hydroxysteroid dehydrogenase type 1 inhibitor.
Blum A; Loerz C; Martin HJ; Staab-Weijnitz CA; Maser E
J Steroid Biochem Mol Biol; 2012 Jan; 128(1-2):51-5. PubMed ID: 22001161
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
Poovitha S; Parani M
BMC Complement Altern Med; 2016 Jul; 16 Suppl 1(Suppl 1):185. PubMed ID: 27454418
[TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapeutic Potential of Bitter Gourd (
Adarmanabadi SMHH; Abadi OJK; Amiri A; Tamannaeifar R; Balanian S; Rasekhjam M; Samiazar MS; Hasanpour S; Peiravi S; Alijanzadeh D; Poudineh M; Amiri H; Mazhari SA; Khademi R; Deravi N; Fathi M
J Integr Neurosci; 2024 Apr; 23(4):86. PubMed ID: 38682220
[TBL] [Abstract][Full Text] [Related]
16. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
[TBL] [Abstract][Full Text] [Related]
17. The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis.
Peter EL; Nagendrappa PB; Kaligirwa A; Ogwang PE; Sesaazi CD
Phytother Res; 2021 Feb; 35(2):637-656. PubMed ID: 32929814
[TBL] [Abstract][Full Text] [Related]
18.
Bortolotti M; Mercatelli D; Polito L
Front Pharmacol; 2019; 10():486. PubMed ID: 31139079
[No Abstract] [Full Text] [Related]
19. Momordica charantia for type 2 diabetes mellitus.
Ooi CP; Yassin Z; Hamid TA
Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
[TBL] [Abstract][Full Text] [Related]
20. Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus.
Cortez-Navarrete M; Martínez-Abundis E; Pérez-Rubio KG; González-Ortiz M; Méndez-Del Villar M
J Med Food; 2018 Jul; 21(7):672-677. PubMed ID: 29431598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
